tiprankstipranks
Healthequity (DE:2HE)
FRANKFURT:2HE

Healthequity Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
13Ratings
11 Buy
1 Hold
1 Sell
Based on 13 analysts giving stock ratings to
Healthequity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2HE Stock Price Prediction

Average Price Target

€81.93
▲(10.72% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Healthequity in the last 3 months. The average price target is €81.93 with a high forecast of €104.62 and a low forecast of €66.96. The average price target represents a 10.72% change from the last price of €74.00.
Highest Price Target€104.62Average Price Target€81.93Lowest Price Target€66.96
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Goldman Sachs
€66.96
Sell
-9.52%
Downside
Reiterated
HealthEquity, Inc (HQY) PT Raised to $64 at Goldman SachsGoldman Sachs analyst Cindy Motz raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $64.00 (from $59.00) while maintaining a Sell rating.
RBC Capital
€73.24
Buy
-1.03%
Downside
Reiterated
Healthequity (HQY) Gets a Buy from RBC Capital
BTIG
€88.93
Buy
20.17%
Upside
Reiterated
Healthequity (HQY) Receives a Buy from BTIG
Guggenheim
€93.11
Buy
25.83%
Upside
Initiated
HealthEquity initiated with a Buy at GuggenheimHealthEquity initiated with a Buy at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Financial Sector
APYRFAllied Properties Real Estate Investment Trust
OPRTOportun Financial
QBEIFQBE Insurance Group Limited
EQGPFEquitable Group
PLMRPalomar Holdings
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

2HE Stock Forecast FAQ

What is DE:2HE’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthequity’s 12-month average price target is €81.93.
    What is DE:2HE’s upside potential, based on the analysts’ average price target?
    Healthequity has 10.72% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DE:2HE a Buy, Sell or Hold?
          Healthequity has a conensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Healthequity’s price target?
            The average price target for Healthequity is €81.93. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is €104.62 ,the lowest forecast is €66.96. The average price target represents 10.72% Increase from the current price of €74.
              What do analysts say about Healthequity?
              Healthequity’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis